Pacira BioSciences (PCRX) Financials: Revenue & Earnings
PCRX$36.38-0.02 -0.07%
$1.45B
Market Cap
103.44
P/E
12.56
Forward P/E
—
Score
Pacira BioSciences (PCRX) Financials: Revenue & Earnings
PCRX price $36.38 -0.02 -0.07%
- Ticker
- PCRX
- Price
- $36.38
- Change
- -0.02 -0.07%
- Market cap ?
- $1.45B
- P/E ?
- 103.44
- Forward P/E ?
- 12.56
- Dividend yield ?
- 0.00%
- Beta ?
- 0.25
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 276371000 | 286630000 | 337277000 | 421026000 | 429647000 | 541533000 | 666823000 | 674978000 | 700966000 | 726411000 |
Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a…
Fair value
PCRX fair value $120.93. Price $36.38. Price is 70% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 76% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 179.51M. Growth 16.01%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 39.86M. Net debt 295.83M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | 0.73 | — | 182.87M |
| 2026-08-04 | 0.73 | 0.65 | 192.40M | 191.06M |
| 2026-04-30 | 0.60 | 0.61 | 177.38M | 171.80M |
| 2026-02-26 | 0.57 | 0.85 | 196.87M | 200.33M |
| 2025-11-06 | 0.70 | 0.65 | 179.52M | 201.93M |
| 2025-08-05 | 0.74 | 0.72 | 181.10M | 182.38M |
| 2025-05-08 | 0.62 | 0.57 | 168.92M | 187.48M |
| 2025-02-27 | 0.91 | 0.78 | 187.25M | 185.38M |
| 2024-11-06 | 0.79 | 0.72 | 168.57M | 179.48M |
| 2024-07-30 | 0.89 | 0.73 | 178.02M | 172.50M |
| 2024-05-07 | 0.62 | 0.64 | 167.12M | 165.35M |
| 2024-02-29 | 0.89 | 0.89 | 181.24M | 181.66M |
| 2023-11-02 | 0.72 | 0.84 | 163.93M | 179.77M |
| 2023-08-02 | 0.78 | 0.81 | 169.47M | 174.60M |
| 2023-05-03 | 0.53 | 0.60 | 160.34M | 158.84M |
| 2023-02-28 | 0.80 | 0.80 | 171.96M | 171.94M |
| 2022-11-03 | 0.64 | 0.73 | 167.47M | 168.33M |
| 2022-08-03 | 0.51 | 0.85 | 169.41M | 170.64M |
| 2022-05-04 | 0.64 | 0.74 | 157.99M | 159.72M |
| 2022-02-24 | 0.97 | 0.83 | 159.19M | 156.29M |
| 2021-11-03 | 0.72 | 0.66 | 127.72M | 140.49M |
| 2021-08-03 | 0.77 | 0.76 | 135.59M | 131.94M |
| 2021-05-04 | 0.53 | 0.59 | 119.03M | 118.63M |
| 2021-02-25 | 0.87 | 0.82 | 128.55M | 131.00M |
| 2020-10-29 | 0.68 | 0.66 | 117.48M | 108.85M |
| 2020-08-06 | 0.12 | 0.16 | 75.50M | 56.63M |
| 2020-05-07 | 0.53 | 0.32 | 105.68M | 91.55M |
| 2020-02-20 | 0.56 | 0.44 | 122.42M | 96.19M |
| 2019-11-07 | 0.48 | 0.34 | 104.69M | 71.97M |
| 2019-08-08 | 0.41 | 0.34 | 102.60M | 87.59M |
| 2019-05-02 | 0.22 | 0.24 | 91.31M | 107.92M |
| 2019-02-28 | 0.47 | 0.25 | 95.11M | 75.67M |
| 2018-11-01 | 0.31 | 0.07 | 83.45M | 21.53M |
| 2018-08-02 | 0.24 | 0.09 | 84.11M | 24.53M |
| 2018-05-03 | 0.02 | 0.06 | 74.61M | 74.61M |
| 2018-02-28 | 0.38 | 0.12 | 79.08M | 20.81M |
| 2017-11-08 | 0.11 | 0.03 | 67.33M | 30.61M |
| 2017-08-02 | -0.11 | -0.10 | 70.93M | 52.67M |
| 2017-05-04 | -0.19 | -0.04 | 69.28M | 14.59M |
| 2017-03-01 | 0.09 | 0.01 | 72.90M | 8.10M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-08 | RIKER LAUREN | Buy | 6.00K | $32.35 | 194.10K |
| 2026-10-08 | RIKER LAUREN | Sell | 6.00K | $36.32 | 217.92K |
| 2026-10-08 | RIKER LAUREN | Sell | 6.00K | $32.35 | 194.10K |
| 2026-08-17 | SLONIN JONATHAN | Sell | 3.04K | $23.23 | 70.62K |
| 2026-06-11 | RIKER LAUREN | Sell | 6.12K | $23.50 | 143.70K |
| 2026-06-10 | Hirawat Samit | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-10 | Hirawat Samit | Buy | 6.41K | — | — |
| 2026-06-10 | CHRISTIE CHRISTOPHER | Buy | 6.41K | — | — |
| 2026-06-10 | CHRISTIE CHRISTOPHER | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-10 | WIGGANS THOMAS G | Buy | 32.67K | $23.42 | 765.25K |
| 2026-06-10 | Young Alethia | Buy | 6.41K | — | — |
| 2026-06-10 | Young Alethia | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-10 | YANG MICHAEL J. | Buy | 6.41K | — | — |
| 2026-06-10 | YANG MICHAEL J. | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-10 | BIGAL MARCELO | Buy | 6.41K | — | — |
| 2026-06-10 | BIGAL MARCELO | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-10 | Froimson Mark | Buy | 6.41K | — | — |
| 2026-06-10 | Froimson Mark | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-10 | Brege Laura | Buy | 6.41K | — | — |
| 2026-06-10 | Brege Laura | Buy | 10.89K | $23.42 | 255.07K |
| 2026-06-09 | WIGGANS THOMAS G | Other | 0 | — | — |
| 2026-06-04 | WILLIAMS KRISTEN | Sell | 10.26K | $22.27 | 228.47K |
| 2026-06-03 | RIKER LAUREN | Sell | 3.19K | $22.32 | 71.13K |
| 2026-06-03 | SLONIN JONATHAN | Sell | 4.73K | $22.32 | 105.53K |
| 2026-06-03 | WILLIAMS KRISTEN | Sell | 8.53K | $22.32 | 190.34K |
| 2026-04-23 | Cross Shawn | Sell | 12.94K | $16.45 | 212.88K |
| 2026-04-23 | Cross Shawn | Buy | 12.94K | $16.45 | 212.88K |
| 2026-04-23 | Cross Shawn | Sell | 12.94K | $25.16 | 325.60K |
| 2026-04-22 | Cross Shawn | Sell | 1.50K | $16.45 | 24.68K |
| 2026-04-22 | Cross Shawn | Buy | 1.50K | $16.45 | 24.68K |
| 2026-04-22 | Cross Shawn | Sell | 1.50K | $25.01 | 37.52K |
| 2026-04-21 | Cross Shawn | Sell | 2.85K | $16.45 | 46.80K |
| 2026-04-21 | Cross Shawn | Buy | 2.85K | $16.45 | 46.80K |
| 2026-04-20 | Cross Shawn | Sell | 7.71K | $16.45 | 126.90K |
| 2026-04-20 | Cross Shawn | Buy | 7.71K | $16.45 | 126.90K |
| 2026-04-20 | Cross Shawn | Sell | 7.71K | $25.14 | 193.93K |
| 2026-03-17 | SLONIN JONATHAN | Sell | 3.26K | $22.82 | 74.42K |
| 2026-03-17 | Froimson Mark | Sell | 500 | $21.81 | 10.90K |
| 2026-02-11 | Cross Shawn | Buy | 49.09K | — | — |
| 2026-02-11 | WILLIAMS KRISTEN | Buy | 54.55K | — | — |
| 2026-02-11 | Teehan Brendan | Buy | 51.71K | — | — |
| 2026-02-11 | RIKER LAUREN | Buy | 19.27K | — | — |
| 2026-02-11 | SLONIN JONATHAN | Buy | 54.55K | — | — |
| 2026-02-11 | Lee Frank D. | Buy | 261.82K | — | — |
| 2026-02-02 | RIKER LAUREN | Sell | 4.00K | $20.81 | 83.24K |
| 2026-02-02 | WILLIAMS KRISTEN | Sell | 13.14K | $20.53 | 269.70K |
| 2026-01-30 | RIKER LAUREN | Sell | 2.75K | $20.54 | 56.51K |
| 2026-01-30 | WILLIAMS KRISTEN | Sell | 17.13K | $20.54 | 351.93K |
| 2026-01-30 | SLONIN JONATHAN | Sell | 6.17K | $20.54 | 126.69K |
| 2026-01-30 | Teehan Brendan | Sell | 5.18K | $20.54 | 106.44K |
| 2026-01-30 | Lee Frank D. | Sell | 41.49K | $20.54 | 852.16K |
| 2026-01-27 | Hirawat Samit | Buy | 39.29K | $19.85 | 779.93K |
| 2026-01-27 | Hirawat Samit | Other | 0 | — | — |
| 2026-01-05 | RIKER LAUREN | Sell | 1.42K | $24.24 | 34.32K |
| 2026-01-02 | SLONIN JONATHAN | Sell | 381 | $24.46 | 9.32K |
| 2026-01-02 | RIKER LAUREN | Sell | 159 | $24.46 | 3.89K |
| 2026-01-02 | Lee Frank D. | Sell | 9.27K | $24.46 | 226.79K |
| 2025-12-31 | Teehan Brendan | Buy | 402 | $10.76 | 4.33K |
| 2025-12-10 | Cross Shawn | Sell | 9.10K | $16.45 | 149.76K |
| 2025-12-10 | Cross Shawn | Buy | 9.10K | $16.45 | 149.76K |
| 2025-12-10 | Cross Shawn | Sell | 9.10K | $25.14 | 228.87K |
| 2025-12-09 | Cross Shawn | Sell | 15.90K | $16.45 | 261.49K |
| 2025-12-09 | Cross Shawn | Buy | 15.90K | $16.45 | 261.49K |
| 2025-12-09 | Cross Shawn | Sell | 15.90K | $25.03 | 397.88K |
| 2025-11-17 | SLONIN JONATHAN | Sell | 3.96K | $24.09 | 95.40K |
| 2025-11-10 | Cross Shawn | Sell | 12.06K | $22.09 | 266.41K |
| 2025-10-31 | Cross Shawn | Sell | 6.69K | $21.38 | 143.03K |
| 2025-09-04 | Ceesay Abraham | Sell | 2.35K | $27.19 | 64.01K |
| 2025-08-07 | BIGAL MARCELO | Sell | 4.91K | $23.67 | 116.27K |
| 2025-08-01 | SLONIN JONATHAN | Sell | 315 | $22.07 | 6.95K |
| 2025-06-11 | Kronenfeld Mark A. | Buy | 6.16K | — | — |
| 2025-06-11 | Kronenfeld Mark A. | Buy | 10.00K | — | — |
| 2025-06-11 | Kronenfeld Mark A. | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | Ceesay Abraham | Buy | 6.16K | — | — |
| 2025-06-11 | Ceesay Abraham | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | Froimson Mark | Buy | 6.16K | — | — |
| 2025-06-11 | Froimson Mark | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | BIGAL MARCELO | Buy | 6.16K | — | — |
| 2025-06-11 | BIGAL MARCELO | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | YANG MICHAEL J. | Buy | 6.16K | — | — |
| 2025-06-11 | YANG MICHAEL J. | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | CHRISTIE CHRISTOPHER | Buy | 6.16K | — | — |
| 2025-06-11 | CHRISTIE CHRISTOPHER | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | Young Alethia | Buy | 6.16K | — | — |
| 2025-06-11 | Young Alethia | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-11 | Brege Laura | Buy | 6.16K | — | — |
| 2025-06-11 | Brege Laura | Buy | 11.28K | $24.34 | 274.53K |
| 2025-06-04 | RIKER LAUREN | Sell | 5.58K | $26.21 | 146.21K |
| 2025-06-04 | WILLIAMS KRISTEN | Sell | 14.38K | $26.24 | 377.23K |
| 2025-06-03 | RIKER LAUREN | Sell | 3.37K | $26.40 | 89.07K |
| 2025-06-03 | WILLIAMS KRISTEN | Sell | 6.16K | $26.40 | 162.68K |
| 2025-06-03 | SLONIN JONATHAN | Sell | 5.08K | $26.40 | 134.22K |
| 2025-02-04 | Teehan Brendan | Buy | 99.50K | $26.59 | 2.65M |
| 2025-02-01 | SLONIN JONATHAN | Buy | 93.60K | — | — |
| 2025-02-01 | WILLIAMS KRISTEN | Buy | 79.20K | — | — |
| 2025-02-01 | Lee Frank D. | Buy | 350.00K | — | — |
| 2025-02-01 | Teehan Brendan | Buy | 54.00K | — | — |
| 2025-02-01 | RIKER LAUREN | Buy | 30.60K | — | — |
| 2025-01-21 | Teehan Brendan | Other | 0 | — | — |
| 2025-01-06 | SLONIN JONATHAN | Sell | 879 | $18.40 | 16.17K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 257, holders +13 vs prior quarter. Ownership 109.86%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 6.71M | -29.53K | -0.44% | 170.13M |
| DOMA PERPETUAL CAPITAL MANAGEMENT LLC | 2.78M | 0 | 0.00% | 70.47M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.41M | -95.05K | -3.80% | 61.05M |
| DIMENSIONAL FUND ADVISORS LP | 2.10M | 42.65K | +2.07% | 53.36M |
| STATE STREET CORP | 2.06M | 140.37K | +7.31% | 52.26M |
| D. E. SHAW & CO., INC. | 1.95M | -32.39K | -1.63% | 49.48M |
| RENAISSANCE TECHNOLOGIES LLC | 1.73M | -91.70K | -5.02% | 43.99M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.69M | -92.48K | -5.18% | 42.92M |
| GOLDMAN SACHS GROUP INC | 1.53M | -42.79K | -2.73% | 38.74M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.16M | 14.87K | +1.30% | 29.40M |
| MORGAN STANLEY | 1.14M | -247.89K | -17.80% | 29.04M |
| AMERICAN CENTURY COMPANIES INC | 1.02M | 180.53K | +21.55% | 25.83M |
| UBS GROUP AG | 920.22K | 358.18K | +63.73% | 23.35M |
| IMPAX ASSET MANAGEMENT GROUP PLC | 750.03K | 0 | 0.00% | 19.03M |
| TWO SIGMA INVESTMENTS, LP | 724.60K | 197.75K | +37.53% | 18.38M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 690.79K | -41.26K | -5.64% | 17.53M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 690.79K | 690.79K | New | 17.53M |
| GAGNON SECURITIES LLC | 608.62K | -8.89K | -1.44% | 15.44M |
| LSV ASSET MANAGEMENT | 608.38K | 91.28K | +17.65% | 15.43M |
| WELLINGTON MANAGEMENT GROUP LLP | 563.46K | 85.08K | +17.78% | 14.29M |
| NORTHERN TRUST CORP | 526.78K | 7.37K | +1.42% | 13.36M |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 411.37K | 0 | 0.00% | 10.44M |
| DEUTSCHE BANK AG\ | 391.10K | -576 | -0.15% | 9.92M |
| JEFFERIES FINANCIAL GROUP INC. | 370.09K | 173.80K | +88.54% | 9.39M |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 362.70K | 31.40K | +9.48% | 9.20M |
Earnings and financials
Pacira BioSciences, Inc. (PCRX) trades at $36.38, with a market cap of $1.45B and a trailing P/E of 103.44. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 276371000 | 286630000 | 337277000 | 421026000 | 429647000 | 541533000 | 666823000 | 674978000 | 700966000 | 726411000 |
Insights · Dividends · Forecast · Financials · Learn